Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-Galactose

  • Yue-Yue Zhou,

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Xiong-Fei Ji ,

    Contributed equally to this work with: Xiong-Fei Ji, Jian-Ping Fu

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Jian-Ping Fu ,

    Contributed equally to this work with: Xiong-Fei Ji, Jian-Ping Fu

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Xiao-Juan Zhu,

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Rong-Hua Li,

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Chang-Kao Mu,

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Chun-Lin Wang ,

    songweiwei@nbu.edu.cn (WWS); wangchunlin@nbu.edu.cn (CLW)

    Current address: School of Marine Science, Ningbo University, Ningbo, China

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯
  • Wei-Wei Song

    songweiwei@nbu.edu.cn (WWS); wangchunlin@nbu.edu.cn (CLW)

    Current address: School of Marine Science, Ningbo University, Ningbo, China

    Affiliations Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University, Ningbo, China, Collaborative Innovation Center for Zhejiang Marine High-efficiency and Healthy Aquaculture, Ningbo University, Ningbo, China

    ⨯

Abstract

D-galactose injection has been shown to induce many changes in mice that represent accelerated aging. This mouse model has been widely used for pharmacological studies of anti-aging agents. The underlying mechanism of D-galactose induced aging remains unclear, however, it appears to relate to glucose and 1ipid metabolic disorders. Currently, there has yet to be a study that focuses on investigating gene expression changes in D-galactose aging mice. In this study, integrated analysis of gas chromatography/mass spectrometry-based metabonomics and gene expression profiles was used to investigate the changes in transcriptional and metabolic profiles in mimetic aging mice injected with D-galactose. Our findings demonstrated that 48 mRNAs were differentially expressed between control and D-galactose mice, and 51 potential biomarkers were identified at the metabolic level. The effects of D-galactose on aging could be attributed to glucose and 1ipid metabolic disorders, oxidative damage, accumulation of advanced glycation end products (AGEs), reduction in abnormal substance elimination, cell apoptosis, and insulin resistance.

Citation: Zhou Y-Y, Ji X-F, Fu J-P, Zhu X-J, Li R-H, Mu C-K, et al. (2015) Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-Galactose. PLoS ONE 10(7): e0132088. https://doi.org/10.1371/journal.pone.0132088

Editor: Linsheng Song, Institute of Oceanology, Chinese Academy of Sciences, CHINA

Received: April 6, 2015; Accepted: June 10, 2015; Published: July 15, 2015

Copyright: © 2015 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: Funding provided by 41176124, National Natural Science Foundation of China to WWS, 41206114, National Natural Science Foundation of China to WWS, LQ12C19002, Zhejiang Province Science and Technology Hall to WWS, ZX2013000403, Zhejiang Province Science and Technology Hall to WWS, Y201224605, Zhejiang Province Department of Education to WWS, XKL11D2102, Ningbo University to WWS, XYL12005, Ningbo University to WWS, and K. C. Wong Magana Fund, Ningbo University to WWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Aging is an extremely complex and multifactorial process that exhibits universal, intrinsic, progressive, and deleterious characteristics[1]. According to the National Bureau of Statistics, people ≥60 years of age account for more than 14.9% of the population in China. In some developed countries, about 20% of the population are >60 years of age. With the expanding elderly population in the world, age-related diseases such as cardiovascular disease, cancer, and diabetes are becoming more common. Along with the pressing problem of age-related diseases, development of anti-aging agents has also become a popular research focus in recent years. Animal models of aging play an important role in anti-aging and drug discovery research. However, using natural aging models usually requires a long and unpredictable experimental time frame. Therefore, to facilitate anti-aging research, we need to create animal models that exhibit representative clinical symptoms of aging in response to designated experimental methods. Some of the current animal models of aging include D-galactose-induced mouse aging model, klotho mutant mouse, and SAMP strains of mice.

D-galactose-treated mice, created by Gong GQ in 1991[2], have been widely used in pharmacological studies of anti-aging agents[3–6]. This animal model exhibits many symptoms that resemble accelerated aging such as decreased activity of antioxidant enzymes, significant increase in malondialdehyde (MDA), accumulation of ROS, poor immune responses, and memory lapses[7–10]. This animal model has the advantages of fast response time and simple operation. Metabolic disorders, especially those involving glucose and lipid metabolism, have long been considered as a main factor contributing to the aging symptoms in D-galactose-treated mice[11]. Although changes in glucose and lipids are currently being investigated, the effects of D-galactose on other metabolites in mimetic aging mice have not received sufficient attention. Despite that the underlying mechanism of natural aging is still yet to be fully understood, it has been confirmed that aging is at least partially caused by changes in gene expression [12,13]. The programmed theories of aging, which argue that aging is naturally “programmed” into our genome, have been proposed to explain aging as a natural process. We, therefore, hypothesize that D-galactose can induce aging by affecting aging-related gene expression.

Metabonomics is a method used to study changes of endogenous small molecules in tissues and biological fluids caused by stimuli such as drugs, genetic effects, and disease processes[14–16]. Metabonomics has many advantages over conventional biochemical treatments. For instance, the metabonomic approach can sensitively monitor a large number of metabolites and can provide metabolic biomarkers that are useful for delineating groupings. Furthermore, metabonomics can measure the concentrations of the molecules of interest and identify their metabolite structures[17]. The use of powerful technologies like cDNA microarray allows us to measure expression levels of thousands of genes simultaneously. Since no study has been carried out to investigate the effect of D-galactose on gene expression, we propose that examining the RNA transcript profiles in D-galactose-treated mice can potentially reveal important changes in gene expression and genetic pathways that will shed light to the underlying mechanism of D-galactose induction of aging.

In this study, changes of metabolites in mimetic aging mice induced by D-galactose were studied comprehensively and systematically using the GC/MS-based metabonomics approach. Gene expression changes of D-galactose–treated mice were studied for the first time using the Agilent Mouse cDNA genechip.

Materials and Methods

Animals and treatments

D-galactose-induced mouse aging model was created as described previously[7]. Twenty male ICR mice (6 weeks of age, 21.32±3.34 g) were obtained from the Experimental Animal Center, Ningbo University, China. Mice were kept under constant temperature (24C±2°C) and humidity (60%) and were maintained on a reversed 12-h light: 12-h dark cycle. After acclimatization to the laboratory environment, ICR mice were randomly divided into two groups: control and D-galactose groups. The D-galactose group was injected with D-galactose (Sigma, St. Louis, MO) at a dose of 120 mg/kg/day for 6 weeks, while the control group was treated with saline (0.9%) of the same volume. Experimental verification of our D-galactose aging model showed that, as compared with the control group, the MDA content of D-galactose-treated mice was significantly increased. In addition, the activities of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase(GSH-Px) were decreased significantly in D-galactose aging mouse livers and brains (S1 and S2 Tables). These observations validated our D-galactose aging mouse model. Liver, which is the central organ responsible for metabolism, plays a vital role in the synthetic decomposition and transformation of various bioactive metabolites. After a trial period of 45 days, the mice were euthanized by exsanguination under diethyl ether anesthesia. Before being euthanized, all mice were fasted 12 hours, but with ad libitum water. Mice were also protected from severe insults prior to euthanasia. Their livers ware removed immediately after exsanguination and stored at -80°C for later experiments. All experiments in this paper were conducted in compliance with the Chinese legislation regarding the use and care of laboratory animals and were approved by the Animal Care and Use Committee of Ningbo University (Permit Number: 0023472).

GC-MS spectroscopy of mouse liver

Liver tissue samples (100 mg) were collected in 2 ml microcentrifuge tubes and 50 μl L-2-chlorophenylalanine (0.1 mg/ml stock in dH2O; Sigma) was added as an internal standard. This was followed by the addition of 0.5 ml of extraction liquid (Vmethanol:Vchloroform = 3:1) to homogenize the tissue in TissueLyser (Qiagen) for 5 min at 70 Hz. The sample was then centrifuged at 225g for 15 min at 4°C. Supernatant of 0.4 ml was transferred to a 2 ml glass autosampler vial, and allowed to dry in a vacuum concentration dryer without heating. Methoxyamination reagent (80 μl) (20 mg/ml in pyridine) was added to the glass autosampler vial at 37°C for 2 h with shaking. Then, BSTFA regent (0.1 ml) (1% TMCS, v/v) was added to the sample aliquot at 70°C for 1 h with shaking. GC/TOFMS analyses were performed when the temperatures dropped to room temperature.

Agilent 7890gas chromatograph system (Agilent 7890A, Agilent, USA) and Pegasus HT time-of-flight mass spectrometer (LECO Chroma TOF PEGASUS 4D, LECO, USA) were used for the GC/TOFMS analysis of samples. With sample injection set at splitless mode, a DB-5MS capillary column (30 m×250-μm inner diameter, 0.25-μm film thickness; J&W Scientific, Folsom,CA) was used for GC separation. The GC was operated at a flow rate of 20 ml min-1 using helium as the carrier gas and the injection temperature was set at 280°C. Temperature program was as follows: initial temperature at 50°C, holds for 1min, increases 10°C/min to 330°C, holds 5min. Electron ionization mass spectrometry at full scan mode (m/z 85–600) was used for MS analysis. The electron energy was set at -70 eV. The transfer line and ion source temperatures were 280°C and 220°C, respectively.

Mouse liver mRNA profiles

Total RNA was extracted from the frozen liver using the mirVanaTM RNA Isolation Kit (Applied Biosystems, Darmstadt, Germany) and then cleaned with Qiagen RNeasyMini kit (Qiagen, Chatsworth, CA), according to the manufacturer’s instructions. The total RNA was quantified using NanoDrop ND-2000 (Thermo Scientific, Wilmington, DE) and the RNA integrity was evaluated using Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). Next, double- strand cDNA was synthesized using PrimeScript RT reagent Kit (TaKaRa BIO, Shiga, Japan), and then labeled with cyanine-3-CTP. Microarray hybridization and the washing steps were performed according to the manufacturer's instructions. The arrays were scanned by Agilent Scanner G2505C in order to generate array image files.

Microarray data validation by real-time polymerase chain reaction

Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to investigate the change in relative expression of genes (T-box 19, Cyp2r1, Jag1, Mfsd2a, Agk, Glo1). Assays were performed using the QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) in an Eppendorf Realplex Real-Time PCR system (Eppendorf, Hamburg, Germany). Gene expression levels were normalized to GAPDH. The experiments were performed in duplicate with liver samples prepared from 3 animals per group. The fold changes of the selected genes were analyzed by the 2-ΔΔCT mothod [18].

Data analysis

Statistical analysis of metabonomics.

The primary data were imported into Micromass Markerlynx software version 4.1 (Waters Corporation, Milford, MA, USA) for preprocessing. The resulting three-dimensional data were analyzed by PCA (principal component analysis), PLS-DA (partial least squares discriminant analysis), and OPLS (orthogonal projections to latent structures-discriminant analysis) using SIMCA-P software Version 13.0 (Umetrics, Umeå, Sweden).

Statistical analysis of microarray data.

Array image files were imported into Feature Extraction software, version 10.7.1.1(Agilent Technologies) for raw data extraction. Raw data were then normalized and analyzed by GeneSpring version 12.5 (AgilentTechnologies). The microarry probes with at least 1 out of 2 conditions flagged in “P” were chosen for further data analysis. Genes that were significantly differentially expressed between the two groups were identified as fold change ≥2.0 with P-value ≤0.05 (t-test).

Results

Results from metabonomics study

To determinate whether D-galactose influence metabolic pattern in control mice and to identify the metabolites that show the most significant change in concentrations, PCA,PLS-DA, and OPLS were used in the following GC/MS data analysis.

Parameters collected from the control and the D-galactose-treated groups were clearly separated by PCA in 95% confidence intervals (Hotelling T2 ellipse) (Fig 1A). Results of PCA showed that the liver metabolic pattern in the D-galactose-treated group was significantly altered, indicating that D-galactose can induce serious metabolic changes in mouse liver. The PLS-DA model was constructed in order to widen the separation of the two groups, as well as a to better understand the variables that are responsible for clustering (Fig 1B). The results of PLS-DA showed that D-galactose treated group was clearly distinctive from the control group. The robustness and predictive ability of PLS-DA model were evaluated by Leave-one-out validation (LOOCV). R2Y = 0.995 and Q2Y = 0.879 (two parameters of LOOCV), which confirmed that the model was fit, stable and reliable for prediction. A permutation test was performed to further verify this model (Fig 1C). R2 and Q2 intercept values were (0.0,0.952) and (0.0,0.14), respectively. The low Q2 intercept value indicated the high reliability and high stability of this model. OPLS is a orthogonal rectification to PLS-DA model, OPLS—DA can filter out unrelated orthogonal signal, thus obtained different metabolites is more reliable(Fig 1D).

thumbnail
Download:
Fig 1. Multivariate statistical analysis of liver GC/MS data.

A)Score plot of PCA obtained from control group(●) and D-galactose group(). B)Score plot of PLS-DA obtained from control group(●) and D-galactose group(). C) The result of permutation test, R2 (gray circle),Q2 (black square). D) Score plot of OPLS model obtained from control group(●) and D-galactose group()

https://doi.org/10.1371/journal.pone.0132088.g001

We screen significantly different metabolites through VIP(variable importance projection) of the first principal component in OPLS-DA model(VIP>1.0) and Student's T test(P<0.05). Metabolites which VIP>1 and p-value <0.05 were selected in Table 1. More details related to these metabolites can be found in S3 Table.

thumbnail
Download:
Table 1. Identification results of potential biomarkers detected by GC/MS in liver of D-galactose group.

Metabolites which VIP>1 and p-value <0.05 have been showed in Table 1. If the value of log2 FOLD CHANGE is positive, the contect of that metabolite in D-galactose is greater than control group, If the value of log2 FOLD CHANGE is negative, the contect of that metabolite in D-galactose is less than control group.

https://doi.org/10.1371/journal.pone.0132088.t001

Table 1 showed that glycometabolism, fatty acid metabolism, transamination, purine metabolites, and some other important metabolites were disturbed in the D-galactose aging group, which may play an vital important role in aging programs.

D-galactose results in metabolic disorders of carbohydrates in the liver.

Compared with control group, liver samples from the D-galactose group contained more than eight times the amount of glucose-1-phosphate. In addition, with the exception of D-Talose-2, the levels of fructose-1, sophorose-2, xylose-1, fucose-1, xylose-2, cellobiose-1, and erythrose-2 were also higher in the D-galactose group. Large amounts of lactic acid, which is the end product of glycolysis, along with decreased levels of fructose-6-phosphate, were detected in our D-galactose group, which was likely the result of increased glycolysis driven by the excessive amount of sugar in the mouse liver.

Disturbance in lipid metabolism was detected in D-galactose mice.

A significant increase in cholesterol concentration was discovered in the D-galactose mouse liver, which was similar to previous reports [11]. Cholesterol is a precursor of steroid hormones and an essential membrane component. Furthermore, cholesterol has been shown to play crucial roles in certain age-related diseases, such as Alzheimer’s diseases, cardiovascular disease, and non-alcoholic fatty liver disease [19,20]. Aging has been shown to increase concentrations of cholesterol precursors (lanosterol and lathosterol) in the liver [21]. In D-galactose mouse livers, we observed a signficant increase in concentration of elaidic acid, which can exert atherogenic effects and lead to cardiovascular disease due to its trans configuration [22]. In addition, palmitoleic acid content was significantly reduced in D-galactose mice. Palmitoleic acid has been shown to improve hepatic lipid metabolism. It can also attenuate hyperglycemia and hypertriglyceridemia by increasing insulin sensitivity [23]. The level of arachidonic acid was also significantly inscreased in D-galactose mouse liver. Arachidonic acid, a polyunsaturated fatty acid, serves as an important component of membrane lipids.

Transamination was enhanced in D-galactose mice.

Transamination is a key step in the biosynthesis of most amino acids. Glutamine and alanine is the reaction substrate and product of transamination respectively. A rapid increase in alanine and a decrease in glutamine were observed in the D-galactose group, which might be attributed to the transamination of excessive glucose. Glutamine is a rate-limiting substrate in GSH (glutathione) formation. Glutamine and cysteine can form GC (γ-glutamylcysteine) in an ATP-dependent reaction. Upon addition of glycine, GC can form GSH. GSH, a quencher for free radicals and a conjugate that enhances drug solubility in water, declines in both natural aging and D-galactose aging mouse liver [24].

Purine metabolic disorder was detected in D-galactose aging mice.

Adenosine 5-monophosphate, l-methyladenosine, xanthine, hypoxanthine, uric acid, allantoic acid, and inosine are intermediates of purine metabolism. We observed that the level of most of these molecules were reduced in D-galactose mice, except for inosine. It has reported that the contect of inosine increased in senescent C57/Bl6 mice[25]. The net release of inosine was enhanced by in vitro aging of lung fibroblasts and had been shown to increase in skin fibroblasts from aged donors[26]. These studies is consistent with our findings. However, there is no more researches on the potential relationship between aging and purine metabolism in mouse liver.

Abnormal levels of metabolic molecules were observed in livers of D-galactose mice.

The levels of sorbitol, sphingosine, and phosphate were increased in D-galactose mouse liver. Sorbitol is a slow-metabolizing isomer of galactitol, which tends to accumulate and causes harmful effects on the body. The levels of sorbitol were found to increase with aging in lens and sciatic nerves [27]. Sphingosine, an 18-carbon amino alcohol, plays important roles in signal transduction during cell apoptosis [27,28]. It has been shown that the basal levels of sphingosine increases in naturally aging animals, which may contribute to the onset of inflammatory like symptoms in aging livers [29]. Phosphate is a vital component of phospholipids in cell membranes and is involved in intermediate cellular signaling [30]. Excess amounts of phosphorus were found in klotho mutant mice [31]. Spermidine participates in multiple biological processes including autophagy induction, which is important in protecting cells from various noxious agents and extending cell lifespan. Spermidine has also been shown to significantly alleviate age-related oxidative protein damages in mice. During hyperglycemia, concentration of 1,5-Anhydroglucito can be dramatically reduced due to impaired tubular reabsorption in the kidneys and thus, level of 1,5-Anhydroglucitol can be used to assess glycemic variability in diabetic patients [32]. The levels of spermidine and 1,5-anhydroglucitol were both decreased in our aging mouse livers, which could potentially explain some of the harmful effects of aging seen in our mouse model.

Results from Microarray study

Compared with control mice, mRNA expression of 30 and 18 genes were down and up regulated in D-galactose-induced aging mice, respectively (absolute fold-change ≥2; P-value ≤0.05). Table 2 listed the parts of genes that showed significantly different expression. More details related to the mRNA expression are included in S4 Table.

thumbnail
Download:
Table 2. Significant mRNA changes induced in liver of D-galactose group.

https://doi.org/10.1371/journal.pone.0132088.t002

Microarray results were validated by RT-PCR.

RT-PCR was performed on six genes (Bhmt-F,T-box 19, Cyp2r1, Jag1, Mfsd2a, Agk, Glo1) in order to independently verify some of our microarray results (Table 3). Consistent with our microarray expression profiling data, expressions of Bhmt-F, T-box 19, Agk were found to be upregulated in the D-galactose groups (Table 3). However, expressions of Cyp2r1, Jag1, Mfsd2a and Glo1 were downregulated in D-galactose groups. The RT-PCR results corresponded to that of the cDNA microarray, with a strong correlation (r2 = 0.995, P <0.01) between the fold change values generated by the cDNA microarray and the RT-PCR analyses.

thumbnail
Download:
Table 3. Independent validation by real-time PCR of 6 genes significantly altered in the liver of D-galactose mice.

https://doi.org/10.1371/journal.pone.0132088.t003

D-galactose might affect cell apoptosis and progression to vascular diseases in mice.

D-galactose induces changes in expression of genes associated with cell apoptosis and vascular diseases (Dusp6, Egr-1, mJagged1, KLK1b26). Dephosphorylating the critical phosphothreonine and phosphotyrosine residues within extracellular signal-regulated kinase (ERK) is the function of Dusp6. ERK is an important signal transduction enzyme that mediates cell proliferation and programmed cell death. The expression of Dusp6 can induce cell apoptosis by inactivating ERK and inhibiting cell proliferation [33]. The level of Egr1 was increased in our D-galactose aging mice, Egr1 can stimulate apoptosis by transactivating the p53 gene[34] and decrease insulin sensitivity [35]. mJagged1 is directly associated with multiple Notch receptors and is involved in the mediating Notch signaling [36–38]. The decrease mJagged1 can promote proliferation of vascular smooth muscle cells (VSMCs) through Notch signaling pathway[39] and then lead to vascular diseases. We observed a decrease in Jagged1 expression in our D-galactose mice which could potentially promote proliferation of vascular smooth muscle cells (VSMCs) through Notch signaling pathway. Kallikrein 1-related petidase b26 (KLK1b26), a member of the kallikrein 1-related petidases (KLK1), can inhibit proliferation of VSMCs [40]. The expression of KLK1b26 was reduced in our D-galactose mice, which could further promote proliferation of VSMCs. Excessive VSMCs is a common pathological feature of the development and progression of atherosclerosis and hypertension [40,41].

D-galactose might lead to impaired degradation mechanisms in mice.

The mRNA expression levels of genes involved in the elimination of abnormal substances (Ube2l6, Cyp2r1,GLO1) were downregulated in D-galactose mice, which could potentially be responsible for some of the aging symptoms of our aging mice.Ubiquitin-conjugating enzyme E2L6 (Ube2l6) is a component of the ubiquitin system that enable the degradation of short-lived and abnormal proteins[42]. Conjugating activity and proteolytic capability of ubiquitin can be inhibited by oxidative damage, which ultimately contribute to the accumulation of deformed proteins in oxidatively challenged aging lens [43]. CYP2R1 (Cytochrome P450, family 2, subfamily r, and polypeptide 1) belongs to the cytochrome P450 family,which plays an important role in detoxification, drug metabolism, and removing waste products [44]. The enzyme GLO1 is an integral component of the glyoxalase system. A major function of the glyoxalase pathway is believed to be detoxification of α-ketoaldehydes, especially the cytotoxic metabolite methylglyoxal (MG) [45].

D-galactose injection might affect immune responses in aging mouse model.

The mRNA expression levels of immune-system-regulating genes (Hc, BIVM and Tmtc3) were upregulated in our D-galactose mice. Hemolytic complement (Hc,C5) belongs to the complement system, which plays key roles in immunity and inflammation. Hc can induce histamine release from basophilic leukocytes as well as from mast cells and stimulate polymorphonuclear leukocytes migration directly to the site of inflammation. In addition, excessive accumulation of complement proteins is the major cause of drusens, whose deposition in the eye is an early sign of age-related macular degeration (AMD) [46]. BIVM possesses Ig-type motifs by including short peptide motifs characteristic of an immunoglobulin (Ig) variable (V) region[47]. Tmtc3 have an impact on the function of immune cell by modulating XBP-1 transcript expression and proteasome activity. [48]. However, there are no studys about the relationship between aging and BIVM and Tmtc3.

D-galactose might affect development in aging mice.

The transcription levels of of development-related genes (Tbx19, ASCL4, CaMK-II) were also increased significantly in D-galactose mice. Tbx19 (T-box19) encodes transcription factors that are involved in developmental regulation. ASCL4 is a transcription factor important in cell differentiation and cell fate determination [49]. CaMK-II encodes a multifunctional Ca2/calmodulin-dependent protein kinase,which plays crucial roles during early development and gametogenesis [50]. There are no studys about the relationship between aging and Tbx19, ASCL4, CaMK-II, but aging is caused by regulating development (such as growth hormone) that has been proved[51].

D-galactose also affects expression of other genes.

The mRNA expression of olfactory receptor gene Olfr1408 and Mfsd2a were descreased in D-galactose mice. The ability of rodents to detect and discriminate odors declines with age. Although the underlying cellular and molecular mechanism for this phenomenon is largely unknown, previous report has demonstrated that expression of olfactory receptor gene varies significantly during the normal aging process [52]. Mfsd2a encodes the important carrier protein for docosahexaenoic acid (DHA). Brain DHA content has been shown to decrease significantly in Mfsd2a-deficient (Mfsd2a-knockout) mice and its deficiency could lead to cognitive deficits and severe anxiety [53]. In addition, we also observed increase in LEP-R and AGK expression in D-galactose mice. LEP-R, a single transmembrane domain receptor of the cytokinereceptor family, functions as a receptor for leptin, which is an adipocyte-derived hormone that activates the sympathetic nervous system, increases energy expenditure, and decreases food intake [54]. Acylglycerol kinase (AGK) is a lipid kinase that phosphorylates either monoacylglycerol to form lysophosphatidic acid (LPA) or phosphorylate diacylglycerol to form phosphatidic acid (PA) [55]. LPA, a multifunctional phospholipid mediator, is involved in a wide range of pathological processes such as hypertension and tumor cell invasion [56]. In addition, AGK expression has also been reported to be upregulated in cancer [57].

Discussion

Oxidative damage and sorbtiol toxicity can lead to aging symptoms observed in D-galactose mice

There are three different metabolic pathways for galactose in the body. The most important pathway is the Leloir pathway, in which galactose is rapidly metabolized into glucose-1-phosphate, a substrate in glycolysis, by four consecutive enzymes. In another pathway, galactose is converted into galacitol (ducitol) by aldose reductase. In the third pathway, galactose-oxidase acts on ducitol and O2 to produce aldehydes and H2O2 [58]. Many studies have demonstrated the potential oxidative damage by H2O2 and O2-, which could accumulated from excessive galactose metabolism, is an important cause of aging in D-galactose mice. It has also been reported that superoxide content increased dramatically in brains and livers of D-galactose aging mice as demonstrated by electron spin resonance spectroscopy (ESR) [59]. Verification of our D-galactose aging model shows that, as compared with control group, the MDA content of D-galactose-treated mice increased significantly while the activities of CAT, SOD, and GSH-Px decreased significantly. These results are in agreement with published experimental data [7] and indicate the validity of our D-galactose model. These results also support the hypothesis that D-galactose-induced aging symptoms are caused by oxidative stress[60].

Galacitol is also produced by excessive metabolism of galactose. We hypothesized that the tissue toxicity of galacitol could be another cause of aging in our D-galactose mice. We observed that sorbitol, the isomer of galactitol, was increased significantly in D-galactose treated mouse livers. Sorbtiol is similar to galacittol in its physiological functions. The accumulation of Sorbitol is known to be harmful to the body[61]. Besides, in certain aging organs such as the lens and the sciatic nerve, the levels of sorbitol were increased significantly after D-galactose injection. Although the relationship between increased galacitol level and aging in D-galactose mice has not yet been established, our study suggests that sorbitol, an isomer of galactitol, might play an important role in the aging process of D-galactose mice.

The process of converting excess glucose into fat and proteins could potentially lead to cardiovascular diseases in D-galactose mice

The level of glucose-1-phosphate was increased significantly in our D-galactose mice. This could promote the process of converting glucose into fat and proteins. In fact, a significant increase in cholesterol, elaidic acid, arachidonic acid concentrations were discovered in our D-galactose mouse liver. In addition, a rapid increase of alanine and decrease of glutamine were observed in the D-galactose mice. All of these results indicate that high concentration of glucose could promote conversion of glucose to fat and transamination. High fat content increases the risk of age-related diseases, especially cardiovascular disease. Furthermore, cholesterol plays crucial roles in Alzheimer’s diseases and non-alcoholic fatty liver disease. Elaidic acid, in particular, possesses atherogenic effects and could lead to cardiovascular diseases [21,22]. Dikran et al. also reported that GSH, a quencher for free radicals and a drug conjugant, declined in naturally aging mouse liver and in D-galactose mouse liver [24]. We speculated that transamination leads to a rapid decrease of glutamine, which in turn, allows glutamine to become a rate-limiting substrate for GSH (glutathione) formation and ultimately leads to the decrease in GSH level. The decreased Jagged1 expression was also observed in D-galactose mice. The Jagged1 protein mediates Notch signaling and its potential effect on vascular diseases by associating directly with multiple Notch receptors [36,37]. In D-galactose mice, the decrease in mJagged1 could promote the proliferation of vascular smooth muscle cells (VSMCs) through the Notch signaling pathway [39]. On the other hand, kallikrein 1-related petidase b26(KLK1b26), a member of the kallikrein 1-related petidases (KLK1), has the opposite effect on the proliferation of VSMCs. In fact, we observed a decrease in KLK1b26 expression in our D-galactose mice, which could further promote the proliferation of VSMCs. Excessive proliferation of VSMCs is a common pathological feature of atherosclerosis and hypertension, both of which become more common with age.

The levels of advanced glycation end products (AGEs) were increased in D-galactose mouse livers

The levels of reducing sugars (fructose1, sophorose2, xylose1, fucose1, xylose2, and erythrose 2) were significantly increased in D-galactose mice. The high concentration of reducing sugars could lead to an increase in Maillard reaction and the accumulation of AGE, which coule be harmful and could contribute to aging by crosslinking proteins and inducing inflammatory responses [62]. Previously studies have demonstrated that AGE level is significantly increased in D-galactose aging mice [63].

Impaired elimination of abnormal substances could contribute to aging in D-galactose mice

Spermidine induces autophagy, which in turn, mediates cytoprotection against a variety of noxious agents and thereby promotes longevity [64,65]. The level of spermidine was decreased in D-galactose mouse liver, which suggests the impaired elimination of foreign substances in the D-galactose induced aging mice. Ubiquitin-conjugating enzyme E2L 6 (Ube2l6) is a component of the ubiquitin system that is responsible for targeting abnormal proteins for degradation. In fact, the level of Ube2l6 was also decreased in D-galactose mouse livers, further indicating a potential deficiency in normal housekeeping functions in D-galactose mice. Reactive oxygen species such as H2O2 and O2-, which are produced by excessive galactose metabolism, could also explain some of the harmful effect of the aging process, mostly due to the observation that oxidative stress can inactivate the ubiquitin conjugation activity by suppressing proteolytic capability [43]. The level of Cytochrome P450 was also decreased in our D-galactose aging mice. Cytochrome P450 is responsible for the biotransformation of most foreign substances in the liver, including 70–80% of all drugs used in the clinical setting [44]. Furthermore, we also observed a decrease in GLO1 level in the D-galactose mice. The GLO1 enzyme is an integral component of the glyoxalase system. A major function of the glyoxalase pathway is believed to be the detoxification of α-ketoaldehydes, particularly a cytotoxic metabolite methylglyoxal (MG) [45].

Accelerated apoptosis and enhanced insulin resistance oberseved in D-galactose mice

Dusp6 has been shown to selectively dephosphorylate the critical phosphothreonine and phosphotyrosine residues within the extracellular signal-regulated kinase (ERK), which is an important signal transducing enzyme involved in mediating cell proliferation and programmed cell death. The decrease of Dusp6 expression level can induce cell apoptosis by inactivating ERK and thereby, inhibit cell proliferation [33]. The level of Dusp6 was decreased in our D-galactose aging mice, which could explain the accelerated cell apoptosis commonly observed in aging.

The level of Egr1 was increased in our D-galactose aging mice, which could be the result of increased oxidative stress and glucose level. It has been demonstrated that oxidative stress can activate the MAPK signaling pathways [66,67]. MAPK, in turn, can upregulate the expression of Egr1. EGR1 stimulates apoptosis by transactivating the p53 gene [34]. High glucose level can also lead to an increase in Egr1 expression. EGR1 has been shown to promote insulin resistance [35]. Furthermore, the palmitoleic acid content was significantly reduced in our D-galactose mouse liver. Palmitoleic acid has been reported to improve hepatic lipid metabolism and attenuate hyperglycemia and hypertriglyceridemia by increasing insulin sensitivity [23]. Many studies have also supported our results by demonstrating that hyperglycemia, hyperinsulinemia, insulin resistance, and hyperlipidemia often occur in D-galactose induced mice [68,69], which may be consequences of the high level of Egr1 expression and the decrease in palmitoleic acid in these mice. Insulin resistance is a primary cause of age-related diseases such as type 2 diabetes, atherosclerosis, and nonalcoholic fatty liver disease (NAFLD) [70].

Conclusion

Metabonomic analysis based on GC/MS and gene expression profile generated by Agilent Mouse mRNA gene chip was performed in this study to investigate changes in the livers of D-galactose induced mice. Based on results of PCA and PLS-DA, parameters collected from the D-galactose treated group and the control group can be clearly distinguished from one another. Using an OPLS model, 51 potential biomarkers were identified in our D-galactose mice at the metabolic level. Forty-nine mRNAs were differentially expressed between control and D-galactose mice. Integrated analysis of the data generated from metabonomics and transcriptomics show that the mechanisms behind D-galactose induction aging likely involve glucose and 1ipid metabolic disorders, increased oxidative damage, accumulation of advanced glycation end products (AGEs), impaired elimination of abnormal substances, accelerated cell apoptosis, and enhanced insulin resistance. The D-galactose mouse model has been widely used for pharmacological studies of anti-aging agents. Our study further confirms the validity of this model by providing an explanation for the possible mechanisms of D-galactose aging induction through promoting metabolic disorders and oxidative damage. Our study is also the first of its kind that suggests D-galactose could induce aging by altering the gene expressions in mice, which would encourage and facilitate future research on development of more effective anti-aging agents.

Supporting Information

S1 Table. The effect of D-galactose on MDA content and the activities of CAT, SOD, GSH-Px in mice liver.

Note: # p<0.05, ## p<0.01 versus normal group

https://doi.org/10.1371/journal.pone.0132088.s001

(DOCX)

S2 Table. The effect of D-galactose on MDA content and the activities of CAT, SOD, GSH-Px in mice brain.

Note: # p<0.05, ## p<0.01 versus normal group.

https://doi.org/10.1371/journal.pone.0132088.s002

(DOCX)

S3 Table. Details of potential biomarkers detected by GC/MS in liver of D-galactose group.

https://doi.org/10.1371/journal.pone.0132088.s003

(XLSX)

S4 Table. Details of significant mRNA changes induced in liver of D-galactose group.

https://doi.org/10.1371/journal.pone.0132088.s004

(DOCX)

S5 Table. The results of total RNA extraction.

https://doi.org/10.1371/journal.pone.0132088.s005

(DOCX)

S6 Table. Standardize data of mRNA chip.

https://doi.org/10.1371/journal.pone.0132088.s006

(XLSX)

S7 Table. The technology roadmap of our experiment and the explanation of supporting information.

https://doi.org/10.1371/journal.pone.0132088.s007

(DOCX)

Acknowledgments

The authors are grateful to Zuo-BengYu,Tian-Long Gao,Yan-Xia Zhu,Hu Dong (Key Laboratory of the Ministry of Education for Applied Marine Biotechnology, Ningbo University) for continuous technical advice and helpful discussion.

This manuscript has been thoroughly edited by a native English speaker from an editing company. Editing Certificate will be provided upon request.

Author Contributions

Conceived and designed the experiments: WWS CLW YYZ. Performed the experiments: YYZ XFJ JPF XJZ. Analyzed the data: WWS YYZ JPF RHL CKM. Contributed reagents/materials/analysis tools: YYZ XFJ XJZ. Wrote the paper: YYZ WWS CLW JPF.

References

  1. 1. Vina J, Borras C, Abdelaziz KM, Garcia-Valles R, Gomez-Cabrera MC. The free radical theory of aging revisited: the cell signaling disruption theory of aging. Antioxidants & redox signaling. 2013;19(8):779–87.
  2. 2. Zhu ZY, Zhu GH. Establishment and measurement of D-galactose induced aging model. Fudan University Journal of Medical Sciences. 2007;34(4):617–9.
  3. 3. Lu J, Zheng YL, Luo L, Wu DM, Sun DX, Feng YJ. Quercetin reverses D-galactose induced neurotoxicity in mouse brain. Behav Brain Res. 2006;171(2):251–60. pmid:16707173.
  4. 4. Lu J, Zheng YL, Wu DM, Luo L, Sun DX, Shan Q. Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochem Pharmacol. 2007;74(7):1078–90. pmid:17692828.
  5. 5. Zhang XL, Jiang B, Li ZB, Hao S, An LJ. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav. 2007;88(1):64–72. pmid:17698178.
  6. 6. Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, et al. Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver. Food and chemical toxicology. 2009;47(2):496–501. pmid:19114082.
  7. 7. Ho SC, Liu JH, Wu RY. Establishment of the mimetic aging effect in mice caused by D-galactose. Biogerontology. 2003;4(1):15–8. pmid:12652185
  8. 8. Salganik RI, Solovyova NA, Dikalov SI, Grishaeva ON, Semenova LA, Popovsky AV. Inherited enhancement of hydroxyl radical generation and lipid peroxidation in the S strain rats results in DNA rearrangements, degenerative diseases, and premature aging. Biochem Biophys Res Commun. 1994;199(2):726–33. pmid:8135816.
  9. 9. Deng HB, Cheng CL, Cui DP, Li DD, Cui LI, Cai NS. Structural and functional changes of immune system in aging mouse induced by D-galactose. Biomedical & Environmental Sciences. 2006;19(6):432–8.
  10. 10. Zhang D, Liu G, Shi J, Zhang J. Coeloglossum viride var. bracteatum extract attenuates D-galactose and NaNO2 induced memory impairment in mice. J Ethnopharmacol. 2006;104(1–2):250–6. pmid:16219437.
  11. 11. Yang SH, Dong XT, Yang GJ. Observation of the anti-aging ability and blood lipid contents of D-gal aging rats. Journal of Chengde Medical College. 2005;22(2):99–101.
  12. 12. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: challenges and insights. Nature Reviews Genetics 2006;7(6):436–48. pmid:16708071.
  13. 13. Hiroshi S, Fujiko A. Aging-related Genes. Anti-Aging Medicine. 2012;9(6):185–91.
  14. 14. Beger RD, Sun J, Schnackenberg LK. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol. 2010;243(2):154–66. Epub 2009/11/26. pmid:19932708.
  15. 15. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29(11):1181–9. pmid:10598751.
  16. 16. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1(2):153–61. pmid:12120097.
  17. 17. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008;455(7216):1054–6. pmid:18948945
  18. 18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protocols. 2008;3(6):1101–8.
  19. 19. Ahmed MH, Ali A. Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first? Scandinavian Journal of Gastroenterology. 2014;49(5):521–7. pmid:24646400
  20. 20. Imam MU, Ishaka A, Ooi DJ, Zamri NDM, Sarega N, Ismail M, et al. Germinated brown rice regulates hepatic cholesterol metabolism and cardiovascular disease risk in hypercholesterolaemic rats. Journal of Functional Foods. 2014;8(3):193–203.
  21. 21. Sun JH, Yu JT, Tan L. The Role of Cholesterol Metabolism in Alzheimer’s Disease. Mol Neurobiol. 2014:1–19.
  22. 22. Du ZY, Degrace P, Gresti J, Loreau O, Clouet P. Vaccenic and elaidic acid equally esterify into triacylglycerols, but differently into phospholipids of fed rat liver cells. Lipids. 2011;46(7):647–57. pmid:21614647.
  23. 23. Yang ZH, Miyahara H, Hatanaka A. Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids in health and disease. 2011;10:120. pmid:21774832.
  24. 24. Toroser D, Sohal RS. Age-associated perturbations in glutathione synthesis in mouse liver. Biochemical Journal. 2007;405(3):583–9. pmid:17461778.
  25. 25. Willems L, Garnham B, Headrick JP. Aging-related changes in myocardial purine metabolism and ischemic tolerance. Experimental Gerontology. 2003;38(10):1169–77. pmid:14580870
  26. 26. Ethier MF, Hickler RB, Dobson JG Jr. Aging increases adenosine and inosine release by human fibroblast cultures. Mechanisms of Ageing and Development. 1989;50(2):159–68. pmid:2601414
  27. 27. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, et al. Sphingosine-1-phosphate in cell growth and cell death. Annals of the rheumatic diseases. 1998;845:11–8. pmid:9668339.
  28. 28. Cuvillier O. Sphingosine in apoptosis signaling. Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids. 2002;1585(2–3):153–62.
  29. 29. Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mechanisms of Ageing and Development. 2000;120(1–3):111–25. pmid:11087909
  30. 30. Takeda E, Taketani Y, Sawada N, Sato T, Yamamoto H. The regulation and function of phosphate in the human body. Biofactors. 2004;21(1–4):345–55. pmid:15630224.
  31. 31. Morishita K, Shirai A, Kubota M, Katakura Y, Nabeshima Y, Takeshige K, et al. The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc. J Nutr. 2001;131(12):3182–8. pmid:11739863.
  32. 32. Frattali AL, Wolf BA. 1,5-Anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus? Clin Chem. 1994;40(11 Pt 1):1991–3. Epub 1994/11/01. pmid:7955366.
  33. 33. Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. American Journal of Pathology. 2003;162(6):1807–15. pmid:12759238.
  34. 34. Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 1998;5(1):3–28. pmid:9476963.
  35. 35. Yu X, Shen N, Zhang ML, Pan FY. Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. the EMBO Journal. 2011;30:3754–65. pmid:21829168
  36. 36. Shimizu K, Chiba S, Kumano K, Hosoya N, Takahashi T, Kanda Y, et al. Mouse Jagged1 Physically Interacts with Notch2 and Other Notch Receptors: Assessment by quantitative methods. Journal of Biological Chemistry. 1999;274(46):32961–9. pmid:10551863
  37. 37. Loomes KM, Underkoffler LA, Morabito J, Gottlieb S, Piccoli DA, Spinner NB, et al. The Expression of Jagged1 in the Developing Mammalian Heart Correlates With Cardiovascular Disease in Alagille Syndrome. Human Molecular Genetics. 1999;8(13):2443–9. pmid:10556292
  38. 38. Wu X, Zhou Q, Huang L, Sun A, Wang K, Zou Y, et al. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells. Cardiovascular Research. 2008;77(4):800–8. pmid:18079106
  39. 39. Qian D, Wu X, Jiang H, Gao P, Kuang C, Wang K, et al. Aging reduces susceptibility of vascular smooth muscle cells to H2O2-induced apoptosis through the down-regulation of Jagged1 expression in endothelial cells. International Journal of Molecular Medicine. 2011;28(2):207–13. pmid:21491077
  40. 40. Lundwall Å, Brattsand M. Kallikrein-related peptidases. Cell Mol Life Sci. 2008;65(13):2019–38. pmid:18344018
  41. 41. Sotiropoulou G, Pampalakis G, Diamandis EP. Functional Roles of Human Kallikrein-related Peptidases. Journal of Biological Chemistry. 2009;284(48):32989–94. pmid:19819870
  42. 42. Hershko A, Ciechanover A. The ubiquitin system. Annual review of biochemistry. 1998;67:425–79. Epub 1998/10/06. pmid:9759494.
  43. 43. Shang F, Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. The Biochemical journal. 1995;307 (Pt 1):297–303. pmid:7717989.
  44. 44. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics. 2013;138(1):103–41.
  45. 45. Kawatani M, Okumura H, Honda K, Kanoh N, Muroi M, Dohmae N, et al. The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proceedings of the National Academy of Sciences. 2008;105(33):11691–6. pmid:18695250.
  46. 46. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis revisited. Progress in Retinal and Eye Research. 2010;29(2):95–112. pmid:19961953
  47. 47. Yoder JA, Hawke NA, Eason DD, Mueller MG, Davids BJ, Gillin FD, et al. BIVM, a novel gene widely distributed among deuterostomes, shares a core sequence with an unusual gene in Giardia lamblia. Genomics. 2002;79(6):750–5. pmid:12036287.
  48. 48. Racapé M, Duong Van Huyen J-P, Danger R, Giral M, Bleicher F, Foucher Y, et al. The Involvement of SMILE/TMTC3 in Endoplasmic Reticulum Stress Response. PloS one. 2011;6(5):e19321. pmid:21603654
  49. 49. Meloni I, Parri V, De Filippis R, Ariani F, Artuso R, Bruttini M, et al. The XLMR gene ACSL4 plays a role in dendritic spine architecture. Neuroscience. 2009;159(2):657–69. Epub 2009/01/27. pmid:19166906.
  50. 50. Rothschild SC, Lister JA, Tombes RM. Differential expression of CaMK-II genes during early zebrafish embryogenesis. Developmental Dynamics. 2007;236(1):295–305. pmid:17103413
  51. 51. Weinert BT, Timiras PS. Invited review: Theories of aging. journal of applied physiology. 2003;95(4):1706–16. pmid:12970376.
  52. 52. Mobley AS, Rodriguez-Gil DJ, Imamura F, Greer CA. Aging in the olfactory system. Trends in Neurosciences. 2014;37(2):77–84. pmid:24361044
  53. 53. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509(7501):503–6. pmid:24828044
  54. 54. Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects—a review. Pediatric Diabetes. 2003;4(2):101–9. pmid:14655266
  55. 55. Waggoner DW, Johnson LB, Mann PC, Morris V, Guastella J, Bajjalieh SM. MuLK, a Eukaryotic Multi-substrate Lipid Kinase. Journal of Biological Chemistry. 2004;279(37):38228–35. pmid:15252046
  56. 56. Sugiura T, Nakane S, Kishimoto S, Waku K, Yoshioka Y, Tokumura A. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. Journal of Lipid Research. 2002;43(12):2049–55. pmid:12454265
  57. 57. Bektas M, Payne SG, Liu H, Goparaju S, Milstien S, Spiegel S. A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. Journal of Cell Biology. 2005;169(5):801–11. Epub 2005/06/09. pmid:15939762.
  58. 58. Bosch A. Classical galactosaemia revisited. J Inherit Metab Dis. 2006;29(4):516–25. pmid:16838075
  59. 59. Cui X, Wang LN, Zuo PP, Han ZT, Fang ZY, Li WB, et al. D-Galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology. 2004;5(5):317–25. pmid:15547319
  60. 60. Hao L, Huang H, Gao J, Marshall C, Chen Y, Xiao M. The influence of gender, age and treatment time on brain oxidative stress and memory impairment induced by d-galactose in mice. Neuroscience Letters. 2014;571:45–9. pmid:24796811
  61. 61. Sheng TE, Lei J. Correlation of Erythrocyte Sorbitol Concentration and Kidney Injury in Diabetic Rats. Food and Drug. 2013;15(3):168–70.
  62. 62. Nass N, Bartling B, Navarrete Santos A, Scheubel RJ, Börgermann J, Silber RE, et al. Advanced glycation end products, diabetes and ageing. Zeitschrift fur Gerontologie und Geriatrie. 2007;40(5):349–56. pmid:17943238
  63. 63. Song X, Bao M, Li D, Li YM. Advanced glycation in d-galactose induced mouse aging model. Mechanisms of Ageing and Development. 1999;108(3):239–51. pmid:10405984
  64. 64. Madeo F, Eisenberg T, Buttner S, Ruckenstuhl C, Kroemer G. Spermidine: a novel autophagy inducer and longevity elixir. Autophagy. 2010;6(1):160–2. pmid:20110777.
  65. 65. LaRocca TJ, Gioscia-Ryan RA, Hearon CM Jr, Seals DR. The autophagy enhancer spermidine reverses arterial aging. Mechanisms of Ageing and Development. 2013;134(7–8):314–20. pmid:23612189
  66. 66. Katiyar SK, Meeran SM. Obesity increases the risk of UV radiation-induced oxidative stress and activation of MAPK and NF-kappaB signaling. Free radical biology & medicine. 2007;42(2):299–310. Epub 2006/12/27. pmid:17189835.
  67. 67. McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxidants & redox signaling. 2006;8(9–10):1775–89. pmid:16987031.
  68. 68. Zhong C, Pan JQ, Lv JH. The effects of baicalin on inhibiting brain aging, glycation-oxidative stress and insulin resistance in D-galactose-induced aging rats. International Journal of pharmaceutical medicine. 2012;18(13):1844–8.
  69. 69. Zhong Y, Tan HR, Pan JQ, Xiao LY. Puerarin inhibits the formation of advanced glycation endproducts and enhances insulin susceptibility in D-galactose-induced rats. Chinese Remedies & Clinics. 2007;7(8):576–9.
  70. 70. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences. Journal of Hepatology. 2007;47(1):142–56. pmid:17512085